Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Haemostasis|July 1, 1996
Highly substituted hydroxyethyl starch (HES200/0.62) leads to Type-I von Willebrand syndrome after repeated administrationJ Treib, A Haass, G Pindur, et al.
Haemostasis|September 1, 1996
Influence of low molecular weight hydroxyethyl starch (HES 40/0.5-0.55) on hemostasis and hemorheologyJ Treib, A Haass, G Pindur, et al.
Infection|November 2, 2001
Incidence and prevalence of infection with human granulocytic ehrlichiosis agent in Germany. A prospective study in young healthy subjectsR Woessner, B C Gaertner, M T Grauer, et al.
Acta Virologica|April 11, 2000
Effects of multiple sclerosis and other inflammatory CNS disorders on tick-borne encephalitis serologyR Woessner, M T Grauer, A Haass, et al.
Infection|July 6, 2000
The Erve virus: possible mode of transmission and reservoirR Woessner, M T Grauer, J Langenbach, et al.
Thrombosis and Haemostasis|December 1, 1995
HES 200/0.5 is not HES 200/0.5. Influence of the C2/C6 hydroxyethylation ratio of hydroxyethyl starch (HES) on hemorheology, coagulation and elimination kineticsJ Treib, A Haass, G Pindur, et al.
Pathophysiology of Haemostasis and Thrombosis|June 2, 2004
Influence of a long-term, high-dose volume therapy with 6% hydroxyethyl starch 130/0.4 or crystalloid solution on hemodynamics, rheology and hemostasis in patients with acute ischemic stroke. Results of a randomized, placebo-controlled, double-blind studyRalph Woessner, Markus T Grauer, Hans-Jürgen Dieterich, et al.
Pageof 4